Author:
Aleemuddin N.M.,Ali Syed Aamir,Ahmedi Urooj,Quadri Syed Mujtaba,Butool Kashifa,Sultana Qursheed
Publisher
Jaypee Brothers Medical Publishing
Reference27 articles.
1. 1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: updated 2005: Available at: www.goldcopd.org. Accessed on February 23, 2018.
2. 2. Miravitlles M, Mayordomo C, Artes M, Sanchez-Agudo L, Nicolau F, Segu JL, on behalf of the EOLO Group. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. Respir Med 1999;93:173–9.
3. 3. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. N Engl J Med 1969;280:397–404.
4. 4. Rosell A, Monso E, Soler N, Angrill J, Riise G, Zalacaín R, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005;165:891–7.
5. 5. Sheti S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465–71.